When will replicel come out?
Hey
@real kombo
Hard to say, but it COULD be by the end of this year. I’ve read a bit of a info about it in folliclethought, this is what it said:
Shiseido/Replicel – Replicel’s hair growth treatment, RCH-01, involves culturing a person’s own hair follicle cells and then re-injecting them back into their scalp. First, a small punch-biopsy is removed from a person’s healthy hair follicles. Then, a specific cell is dissected from the follicle and cultured in a growth medium. The cells are replicated into the millions and then injected back into the person’s scalp. There is a short video about the procedure
here. Replicel has been involved in a lot of activity over the past years to further develop their RCH-01 treatment into a worldwide success. For starters, Replicel created a partnership with Shiseido, which is the fourth largest cosmetic company in the world. In May 2014
Shiseido opened a huge biotechnology facility in Japan to accelerate the launch of Replicel’s hair technology RCH-01. This endeavor coincides perfectly with Japan’s new legislation which is designed to help expedite the trial process for stem cell technologies. In other words, Japan is an ideal place to launch a new cellular-based technology and get it to market quickly. To be clear, Shiseido and Replicel are separate companies. Replicel has licensed Shiseido the rights to bring RCH-01 to the world through an expedited regulatory path in Japan. It is worth mentioning that Shiseido also has its
own scientistswho are working on a separate hair regeneration technique using iPS cells. A treatment using iPS cells would be very advanced and could potentially produce an unlimited amount of hair regrowth.
Points of Interest: Shiseido is
currently trialing Replicel’s RCH-01 in Japan for market approval by the end of 2018. Replicel is also planning on launching its own RCH-01 Phase 2 trial, hopefully sometime in 2017, for the regulatory approval pathway in North America.
Status: Shiseido’s Japan trial has launched in 3rd quarter 2016. Potential market release by 3rd quarter 2018 in Japan.
There is also a lot of info about other promising treatments to come including Histogen, Brotzu, Follica, RiverTown therapeutics, Allergen, Samumed and a few others. Here’s the article:
http://www.folliclethought.com/tag/brotzu-lotion/
It looks like Brotzu is the closest to release.
Hopefully it’s not too expensive, because I would love to try it. I also think Histogen and RiverTown therapeutics looks really promising. Aclaris could really be somthing too. Saying very cautiously optimistic.